FI962749A - Uusia heterosyklisiä yhdisteitä - Google Patents

Uusia heterosyklisiä yhdisteitä Download PDF

Info

Publication number
FI962749A
FI962749A FI962749A FI962749A FI962749A FI 962749 A FI962749 A FI 962749A FI 962749 A FI962749 A FI 962749A FI 962749 A FI962749 A FI 962749A FI 962749 A FI962749 A FI 962749A
Authority
FI
Finland
Prior art keywords
heterocyclic compounds
new heterocyclic
substituted
hyperalgesic
painful
Prior art date
Application number
FI962749A
Other languages
English (en)
Swedish (sv)
Other versions
FI962749A0 (fi
FI114025B (fi
Inventor
Knud Erik Andersen
Uffe Bang Olsen
Hans Petersen
Frederik Christian Groenvald
Ursula Sonnewald
Tine Krogh Joergensen
Henrik Sune Andersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI962749A0 publication Critical patent/FI962749A0/fi
Publication of FI962749A publication Critical patent/FI962749A/fi
Application granted granted Critical
Publication of FI114025B publication Critical patent/FI114025B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
FI962749A 1994-01-04 1996-07-04 Uudet heterosykliset yhdisteet FI114025B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK1994 1994-01-04
DK1994 1994-01-04
DK129094 1994-11-09
DK129094 1994-11-09
DK9500002 1995-01-03
PCT/DK1995/000002 WO1995018793A1 (en) 1994-01-04 1995-01-03 Novel heterocyclic compounds

Publications (3)

Publication Number Publication Date
FI962749A0 FI962749A0 (fi) 1996-07-04
FI962749A true FI962749A (fi) 1996-09-04
FI114025B FI114025B (fi) 2004-07-30

Family

ID=26063135

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962749A FI114025B (fi) 1994-01-04 1996-07-04 Uudet heterosykliset yhdisteet

Country Status (31)

Country Link
US (8) US5595989A (fi)
EP (1) EP0738262B1 (fi)
JP (1) JP2944221B2 (fi)
KR (1) KR100329450B1 (fi)
CN (1) CN1083431C (fi)
AT (1) ATE191909T1 (fi)
AU (1) AU691858B2 (fi)
BG (1) BG100692A (fi)
BR (1) BR9506452A (fi)
CA (1) CA2180238A1 (fi)
CZ (1) CZ286109B6 (fi)
DE (1) DE69516394T2 (fi)
DK (1) DK0738262T3 (fi)
ES (1) ES2147837T3 (fi)
FI (1) FI114025B (fi)
GR (1) GR3033967T3 (fi)
HU (1) HUT75878A (fi)
IL (1) IL112222A (fi)
MY (1) MY113463A (fi)
NO (1) NO306295B1 (fi)
NZ (1) NZ277763A (fi)
PE (1) PE45095A1 (fi)
PL (1) PL180209B1 (fi)
PT (1) PT738262E (fi)
RU (1) RU2167152C2 (fi)
SG (1) SG50602A1 (fi)
SI (1) SI9520023A (fi)
SK (1) SK88196A3 (fi)
TW (1) TW300887B (fi)
UA (1) UA47396C2 (fi)
WO (1) WO1995018793A1 (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110913A (en) * 1994-01-04 2000-08-29 Novo Nordisk A/S N-substituted azaheterocyclic carboxylic acids and esters thereof
US6239148B1 (en) * 1994-01-04 2001-05-29 Novo Nordisk A/S N-substituted azaheterocyclic carboxylic acids and esters thereof
MY113463A (en) * 1994-01-04 2002-03-30 Novo Nordisk As Novel heterocyclic compounds
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
US5698551A (en) * 1995-04-07 1997-12-16 Novo Nordisk A/S Heterocyclic compounds
US5952352A (en) * 1995-04-07 1999-09-14 Novo Nordisk A/S Heterocyclic compounds
US5716949A (en) * 1995-04-07 1998-02-10 Novo Nordisk A/S Heterocyclic compounds
UA54385C2 (uk) * 1995-04-07 2003-03-17 Ново Нордіск А/С N-заміщені азагетероциклічні карбонові кислоти та їх ефіри, спосіб їх одержання, фармацевтична композиція та спосіб лікування
AU704825B2 (en) * 1995-12-15 1999-05-06 Novo Nordisk A/S Novel method
US6323206B1 (en) 1996-07-12 2001-11-27 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
IL129122A0 (en) * 1996-10-04 2000-02-17 Novo Nordisk As N-substituted azaheterocyclic compounds
ZA978792B (en) * 1996-10-04 1998-04-06 Novo Nordisk As N-substituted azaheterocyclic compounds.
ES2194217T3 (es) * 1996-10-04 2003-11-16 Novo Nordisk As Spperazinas 1,4-disustituidas.
US6040318A (en) * 1997-06-25 2000-03-21 Novo Nordisk A/S Tricycle substituted with azaheterocyclic carboxylic acids
RU2235094C2 (ru) 1997-10-27 2004-08-27 Др. Редди`З Лабораториз Лимитед Бета-арил-альфа-оксизамещенные алкилкарбоновые кислоты, способы их получения, промежуточные соединения, способы их получения, фармацевтическая композиция, способы лечения или предупреждения заболеваний на основе новых соединений
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
AU2335699A (en) * 1998-01-21 1999-08-09 Kyowa Hakko Kogyo Co. Ltd. Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
AU2331999A (en) 1998-01-21 1999-08-09 Kyowa Hakko Kogyo Co. Ltd. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) * 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6468996B1 (en) * 1998-10-21 2002-10-22 Novo Nordisk A/S Substituted hetero-polycyclic compounds as PPARα and PPARγ activators
EP1140084A1 (en) * 1998-12-22 2001-10-10 Novo Nordisk A/S Novel formulation
US6207682B1 (en) 1998-12-22 2001-03-27 Novo Nordisk A/S Modified release formulations containing (R)-1-(10,11-dihydro-5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1propyl)-3-piperidinecarboxylic acid
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US7541365B2 (en) * 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US20040087642A1 (en) * 2002-10-24 2004-05-06 Zeldis Jerome B. Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
TWI291467B (en) * 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
WO2004112705A2 (en) * 2003-06-16 2004-12-29 Hypnion, Inc. Methods for treating sleep disorders
JP2010502621A (ja) * 2006-09-01 2010-01-28 イミユーン・コントロール・インコーポレーテツド リンパ球の活性化に関連した病気を治療するための新規な組成物および方法
TW201711999A (zh) 2015-09-03 2017-04-01 佛瑪治療公司 ﹝6,6﹞稠合雙環組蛋白脫乙醯基酶8(hdac8)抑制劑
JP2020526592A (ja) 2017-07-13 2020-08-31 トニックス ファーマシューティカルズ ホールディング コーポレーション シクロベンザプリン類似体及びアミトリプチレン類似体
CN115850232B (zh) * 2023-02-16 2023-05-26 广州佳途科技股份有限公司 一种氟哌噻吨ep杂质h的制备方法及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3316249A (en) * 1967-04-25 Part a.xmethyl n n-(z-diethylaminoethyl)-n-(z- nitrophenyl) anthranilate hydrochloride
US2931810A (en) * 1960-04-05 Phenothiazine derivatives
BE552557A (fi) * 1955-11-15
NL108827C (fi) * 1956-04-09
BE562299A (fi) * 1956-11-15
BE560750A (fi) * 1957-07-26
NL222355A (fi) * 1957-11-05
FR1216268A (fr) * 1958-04-24 1960-04-25 Rhone Poulenc Sa Nouveaux dérivés de la phénothiazine à chaîne pipéridine substituée par une fonction amide et leur préparation
US3069432A (en) * 1961-02-20 1962-12-18 Olin Mathieson 5-(aminoalkyl)-5, 11-dihydrodibenzo-oxazepines
DE1159954B (de) * 1961-11-25 1963-12-27 Boehringer & Soehne Gmbh Verfahren zur Herstellung neuer 10-(Alkoxypiperidinopropyl)-phenthiazine und ihrer Salze
US3157658A (en) * 1963-07-05 1964-11-17 Searle & Co 1-carbalkoxy-4-(9-xanthenyl) piperazines and related compounds
FR145F (fi) * 1964-06-01
US3886170A (en) * 1974-04-22 1975-05-27 Robins Co Inc A H 5-(3-)SUBSTITUTED-10,11-DIHYDRO-5H-dibenz{8 b,f{9 azepines
US4888335A (en) * 1988-07-25 1989-12-19 Mcneilab, Inc. 3-alkoxy-2-aminopropyl heterocyclic amines and their use as cardiovascular agents
US5296602A (en) * 1991-03-18 1994-03-22 Sloan-Kettering Institute For Cancer Research Multisubstituted 1-hydroxy-9-acridones with anticancer activity
US5420123A (en) * 1992-12-21 1995-05-30 Bristol-Myers Squibb Company Dibenzodiazepine endothelin antagonists
US5538986A (en) * 1993-12-06 1996-07-23 Schering Corporation Tricyclic derivatives, compositions and methods of use
MY113463A (en) * 1994-01-04 2002-03-30 Novo Nordisk As Novel heterocyclic compounds

Also Published As

Publication number Publication date
DE69516394D1 (de) 2000-05-25
CZ192196A3 (en) 1997-05-14
RU2167152C2 (ru) 2001-05-20
US5795888A (en) 1998-08-18
US5688788A (en) 1997-11-18
PT738262E (pt) 2000-10-31
EP0738262B1 (en) 2000-04-19
CZ286109B6 (cs) 2000-01-12
CN1142226A (zh) 1997-02-05
TW300887B (fi) 1997-03-21
IL112222A (en) 1999-12-31
AU691858B2 (en) 1998-05-28
DE69516394T2 (de) 2000-10-26
NZ277763A (en) 2001-11-30
SK88196A3 (en) 1997-06-04
US5693649A (en) 1997-12-02
PL180209B1 (pl) 2001-01-31
US6043239A (en) 2000-03-28
CN1083431C (zh) 2002-04-24
CA2180238A1 (en) 1995-07-13
GR3033967T3 (en) 2000-11-30
HU9601842D0 (en) 1996-09-30
FI962749A0 (fi) 1996-07-04
US5595989A (en) 1997-01-21
US5712292A (en) 1998-01-27
MY113463A (en) 2002-03-30
PE45095A1 (es) 1995-12-18
NO962811L (no) 1996-09-04
UA47396C2 (uk) 2002-07-15
KR100329450B1 (ko) 2002-10-04
NO306295B1 (no) 1999-10-18
ES2147837T3 (es) 2000-10-01
BG100692A (en) 1997-09-30
US5721254A (en) 1998-02-24
EP0738262A1 (en) 1996-10-23
JP2944221B2 (ja) 1999-08-30
IL112222A0 (en) 1995-03-30
ATE191909T1 (de) 2000-05-15
FI114025B (fi) 2004-07-30
DK0738262T3 (da) 2000-09-04
JPH09507239A (ja) 1997-07-22
SI9520023A (en) 1997-04-30
SG50602A1 (en) 1998-07-20
NO962811D0 (no) 1996-07-03
AU1311095A (en) 1995-08-01
BR9506452A (pt) 1997-09-02
US5668129A (en) 1997-09-16
WO1995018793A1 (en) 1995-07-13
HUT75878A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
FI962749A (fi) Uusia heterosyklisiä yhdisteitä
MX9707531A (es) Nuevos compuestos heterociclicos.
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
FI956119A0 (fi) Fenyyliheterosyklejä syklo-oksigenaasi-2-inhibiittoreina
EA200100971A1 (ru) Новые соединения и композиции в качестве ингибиторов протеазы
PE59099A1 (es) Nuevos derivados del acido hexanoico
PT1023267E (pt) Compostos de piridilo e composicoes farmaceuticas que os contem
BR9713178A (pt) Inbidores espirocìclicos da metaloprotease.
DE69615169D1 (de) N-substituierte azaheterocyclische Carbonsäuren und ihre Alkylester
ES2173858T3 (es) Analogos de huperzina a.
DE60121986D1 (de) Triptpolidanaloge zur verendung in der behandlung von autoimmunbedingten und entzündlichen erkrankungen
DE3763863D1 (de) Substituierte tetrahydro-3-pyridincarbonsaeuren, ihre ester und amide als cholinergische mittel.
BR0109328A (pt) Inibidores de metaloprotease n-substituìdos, contendo cadeia lateral heterocìclica
AU5100496A (en) Novel heterocyclic compounds
AR043186A1 (es) Indozolamidas dotadas de actividad analgesica, metodo de preparacion de las mismas y compuesto farmaceutico que las comprende
IL117812A0 (en) N-substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
HUP0203118A2 (hu) Béta-diszubsztituált metalloproteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
UY28618A1 (es) Nuevos indoles sustituidos de piperidina o heteroderivados de los mismos
HUP0000307A2 (hu) Y Neuropeptid antagonisták és ezeket tartalmazó gyógyászati készítmények
ATE157086T1 (de) N-substituierte azaheterozyklische carbonsäuren und pharmazeutische zusammensetzung